吉屋 匠平

Medicine and Dentistry

1. Patient 100%
2. Donor 66%
3. Hepatocellular Carcinoma 56%
4. Liver Transplantation 54%
5. Hepatectomy 44%
6. Surgery 23%
7. Inpatient 23%
8. Neoplasm 17%
9. Overall Survival 14%
10. Survival Rate 12%
11. Hepatic Vein 11%
12. Prognosis 11%
13. Recurrence Free Survival 10%
14. Lymphocyte 9%
15. Graft Survival 9%
16. Albumin 8%
17. Recurrent Disease 8%
18. Platelet 8%
19. Incidence 7%
20. Surgical Anastomosis 7%
21. Programmed Death 1 Ligand 1 7%
22. Portal Vein Thrombosis 7%
23. Common Hepatic Artery 7%
24. Sepsis 7%
25. Interferon 6%
26. Therapeutic Procedure 6%
27. Adult 6%
28. Analysis 6%
29. Stone 6%
30. Multivariate Analysis 6%
31. Hepatic Portal Vein 5%
32. Malignant Neoplasm 5%
33. Combination Therapy 5%
34. Bleeding 5%
35. Cancer 5%
36. Predictor 5%
37. Serum 5%
38. Endoscopic Retrograde Cholangiopancreatography 5%
39. Cholangiocarcinoma 5%
40. Liver 5%